Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 102, Issue 2, Pages 157-162
Publisher
Wiley
Online
2018-10-23
DOI
10.1111/ejh.13187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report
- (2018) Kenta Ogawa et al. INVESTIGATIONAL NEW DRUGS
- Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders
- (2018) Giulia C. Leonardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma
- (2018) Kentaro Tokumo et al. LUNG CANCER
- Post-Babesiosis Warm Autoimmune Hemolytic Anemia
- (2017) Ann E. Woolley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project
- (2017) Beatrice J. Edwards et al. Drugs in research & development
- Thyroid dysfunctions secondary to cancer immunotherapy
- (2017) P. Chalan et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Immunotherapy-associated autoimmune hemolytic anemia
- (2017) Uqba Khan et al. Journal for ImmunoTherapy of Cancer
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Autoimmune hemolytic anemia after nivolumab treatment in Hodgkin lymphoma responsive to immunosuppressive treatment. A case report
- (2016) Magalie P. Tardy et al. HEMATOLOGICAL ONCOLOGY
- Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma
- (2016) Benjamin Y. Kong et al. MELANOMA RESEARCH
- Immunotherapy-Associated Hemolytic Anemia with Pure Red-Cell Aplasia
- (2016) Ranjit Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and pulmonary adverse events in patients treated withBCR-ABLinhibitors: Data from the FDA Adverse Event Reporting System
- (2015) Jorge Cortes et al. AMERICAN JOURNAL OF HEMATOLOGY
- The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment
- (2015) G. K. Pennock et al. ONCOLOGIST
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients
- (2014) Mathilde Roumier et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immune Checkpoint Blockade
- (2014) Jarushka Naidoo et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Warm autoimmune hemolytic anemia: Advances in pathophysiology and treatment
- (2014) M. Michel PRESSE MEDICALE
- Fatal Immune Hemolytic Anemia Following Allogeneic Stem Cell Transplantation: Report of 2 Cases and Review of Literature
- (2013) Jordina Rovira et al. TRANSFUSION MEDICINE REVIEWS
- Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system
- (2012) G. Sarganas et al. NEURO-ONCOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Warm Autoimmune Hemolytic Anemia: Recent Progress in Understanding the Immunobiology and the Treatment
- (2010) Melca M.O. Barros et al. TRANSFUSION MEDICINE REVIEWS
- Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literature
- (2010) Joe Puthenparambil et al. WIENER KLINISCHE WOCHENSCHRIFT
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Drug-induced immune hemolytic anemia
- (2009) G. Garratty Hematology-American Society of Hematology Education Program
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started